James Campbell, M.D., seeks new opportunities to invest in innovative technologies in the areas of therapeutics and devices, and he works with entrepreneurs at the early stages of company formation. Dr. Campbell is a director of InterWest portfolio companies Anesiva and Amplimmune, and is the CEO and a director of Arcion, also an InterWest portfolio company. He is the founder and chairman of the non-profit organization, the American Pain Foundation.

Dr. Campbell has a long record of accomplishment in academic medicine and neuroscience research. He serves as Professor of Neurosurgery and Director of the Blaustein Pain Treatment Center at the School of Medicine at Johns Hopkins University, and in the past, served as Director of the Residency Training Program for the Department of Neurosurgery at Johns Hopkins. He has authored several books, published well over 100 peer-reviewed research papers and has served on the editorial board of several academic journals. Dr. Campbell has received many national awards for research and public service, including the Jacob Javits Neuroscience Investigator Award from the National Institutes of Health, and the Grass Award from the Society of Neurological Surgery. He also has received the Kerr Award for Research from the American Pain Society. He has served as consultant/advisor for several biopharmaceutical companies and holds many patents in the life sciences. Currently, Dr. Campbell owns the founding intellectual property for Anesiva, an InterWest portfolio company.

Dr. Campbell received his B.A. from the University of Michigan with High Honors and High Distinction, and his M.D. degree from Yale University. He completed his residency in Neurosurgery at the Johns Hopkins University, and also pursued post-doctoral training in Neurophysiology in the Department of Physiology at Johns Hopkins. Dr. Campbell is a Diplomate of the American Board of Neurological Surgery.